Neurological Biomarkers Market Innovations Revolutionizing Healthcare

According to the Persistence Market Research, the global neurological biomarkers market value is estimated to grow from US$ 9.5 Billion in 2025 to US$ 19.1 Billion by 2032. The market is projected to record a CAGR of 10.4% by 2032. The rising prevalence of neurological disorders and advances in molecular biology, such as gene sequencing and proteomics, alongside neuroimaging techniques are expanding the application of biomarkers in diagnostics and treatment. According to the World Health Organization, the global burden of neurological diseases is expected to increase substantially, further driving demand for early diagnostic tools.